FENNEC PHARMACEUTICALS INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2017 | $-675.0K | $-675.0K | — | $41.0K |
| Jun 2017 | $-688.0K | $-688.0K | — | $461.0K |
| Sep 2017 | $-958.0K | $-958.0K | — | $907.0K |
| Mar 2018 | $-1.7M | $-1.7M | — | $174.0K |
| Jun 2018 | $-1.6M | $-1.6M | — | $1.2M |
| Sep 2018 | $-1.6M | $-1.6M | — | $222.0K |
| Mar 2019 | $-2.5M | $-2.5M | — | $221.0K |
| Jun 2019 | $-2.8M | $-2.8M | — | $1.7M |
| Sep 2019 | $-2.2M | $-2.2M | — | $314.0K |
| Mar 2020 | $-3.7M | $-3.7M | — | $391.0K |
| Jun 2020 | $-3.1M | $-3.1M | — | $522.0K |
| Sep 2020 | $-5.4M | $-5.4M | — | $1.2M |
| Mar 2021 | $-3.6M | $-3.6M | — | $587.0K |
| Jun 2021 | $-4.4M | $-4.4M | — | $1.3M |
| Sep 2021 | $-3.0M | $-3.0M | — | $917.0K |
| Mar 2022 | $-2.9M | $-2.9M | — | $399.0K |
| Jun 2022 | $-3.4M | $-3.4M | — | — |
| Sep 2022 | $-5.0M | $-5.0M | — | — |
| Mar 2023 | $-5.6M | $-5.6M | — | $1.1M |
| Jun 2023 | $-3.9M | $-3.9M | — | — |
| Sep 2023 | $-2.8M | $-2.8M | — | — |
| Mar 2024 | $39.0M | $39.0M | — | $1.2M |
| Jun 2024 | $-8.4M | $-8.4M | — | — |
| Sep 2024 | $-2.2M | $-2.2M | — | — |
| Mar 2025 | $-4.3M | $-4.3M | — | $798.0K |
| Jun 2025 | $-3.7M | $-3.7M | — | — |
| Sep 2025 | $1.5M | $1.5M | — | — |
| Mar 2026 | $2.4M | $2.4M | — | $990.0K |
| Jun 2026 | $50.0K | $50.0K | — | — |